Ownership and insider activity for AptarGroup, Inc. (ATR): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage.
Price
| Price | $127.17 (closing price, October 28, 2026) |
| Market Cap | $8.1B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-11 | Ackerman Daniel | |||
| 2018-02-10 | Ackerman Daniel | 17,500 | $1.3M | |
| 2024-03-15 | Ackerman Daniel | 2,971 | $331K | |
| 2025-03-15 | Ackerman Daniel | 2,485 | $350K | |
| 2026-03-17 | Ackerman Daniel | 2,451 | $362K | |
| 2027-03-19 | Ackerman Daniel | 2,967 | $368K | |
| 2026-09-02 | Vinczeller Shiela | S-Sale | 765 | $100K |
| 2026-09-01 | Touya Gael | A-Award | 2,637 | |
| 2026-09-01 | Touya Gael | A-Award | 9,531 | $1.2M |
| 2026-08-27 | Touya Gael | S-Sale | 3,415 | $457K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $466.3M | $712.6M | $261.8M | $242.0M | $300.1M | $122.9M | $141.7M | $223.6M | $223.8M | $402.4M |
| Short-term Investments | 0 | 0 | 0 | 0 | $243,000 | $740,000 | 0 | 0 | $2.3M | $7.1M |
| Receivables | $433.1M | $510.4M | $569.6M | $558.4M | $566.6M | $671.4M | $677.0M | $677.8M | $658.1M | $803.8M |
| Inventory | $296.9M | $337.2M | $381.1M | $375.8M | $379.4M | $441.5M | $486.8M | $513.1M | $461.8M | $537.8M |
| Total Current Assets | $1.27B | $1.67B | $1.33B | $1.29B | $1.37B | $1.36B | $1.43B | $1.55B | $1.48B | $1.89B |
| Property, Plant & Equipment | $784.3M | $867.9M | $991.6M | $1.16B | $1.27B | $1.34B | $1.40B | $1.54B | $1.51B | $1.74B |
| Goodwill | $407.5M | $443.9M | $712.1M | $763.5M | $898.5M | $974.2M | $945.6M | $963.4M | $936.3M | $1.08B |
| Intangible Assets | $94.5M | $95.5M | $254.9M | $291.1M | $344.3M | $362.3M | $315.7M | $283.2M | $254.8M | $255.3M |
| Total Assets | $2.61B | $3.14B | $3.38B | $3.56B | $3.99B | $4.14B | $4.20B | $4.45B | $4.43B | $5.25B |
| Accounts Payable | $115.5M | $153.9M | $164.5M | $192.7M | $243.7M | $285.3M | $320.3M | $328.6M | $296.0M | $340.6M |
| Short-term Debt | $173.8M | $66.2M | $164.0M | $110.2M | $113.6M | $285.9M | $122.8M | $458.2M | $338.3M | $343.5M |
| Total Current Liabilities | $543.0M | $527.7M | $689.2M | $683.3M | $780.3M | $982.5M | $917.2M | $1.25B | $1.07B | $1.17B |
| Long-term Debt | $772.7M | $1.19B | $1.13B | $1.09B | $1.05B | $907.0M | $1.05B | $681.2M | $688.1M | $1.14B |
| Total Liabilities | $1.43B | $1.83B | $1.95B | $1.99B | $2.14B | $2.16B | $2.14B | $2.13B | $1.95B | $2.54B |
| Retained Earnings | $1.20B | $1.30B | $1.37B | $1.52B | $1.64B | $1.79B | $1.93B | $2.11B | $2.37B | $2.64B |
| Total Equity | $1.17B | $1.31B | $1.42B | $1.57B | $1.85B | $1.97B | $2.05B | $2.31B | $2.47B | $2.67B |
| Total Debt | $948.1M | $1.26B | $1.29B | $1.25B | $1.23B | $1.24B | $1.22B | $1.18B | $1.08B | $1.53B |
| Net Debt | $481.8M | $545.4M | $1.03B | $1.01B | $924.7M | $1.12B | $1.08B | $961.0M | $849.9M | $1.12B |
| Working Capital | $727.2M | $1.14B | $641.6M | $608.0M | $588.7M | $375.7M | $513.1M | $298.0M | $410.1M | $727.1M |
Financial Health
| Debt / Equity | 0.54 |
| Current Ratio | 1.61 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 3.81 |
Profitability
| Return on Equity | 13.52% |
| Return on Invested Capital | 9.15% |
| Return on Assets | 7.06% |
| Gross Margin | 28.26% |
| Operating Margin | 12.37% |
| Net Margin | 9.22% |
Related companies: AMCR · WST · SON · SLGN · STVN
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of ATR: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks